564
S. E. Boiadjiev and D. A. Lightner
5-Ethyl-2,3,6-trimethylpyrrolo[2,3-f]indolizine-7,9-dione (3, C15H16N2O2)
1
Yield 75%; mp 337–339ꢄC (dec); H NMR ((CD3)2SO at 60ꢄC): ꢅ ¼ 1.15 (3H, t, J ¼ 7.6 Hz), 1.82
(3H, s), 2.06 (3H, s), 2.20 (3H, s), 2.55 (2H, q, J ¼ 7.6 Hz), 6.75 (1H, s), 11.90 (1H, br.s) ppm; 13C
NMR ((CD3)2SO at 60ꢄC): ꢅ ¼ 7.44, 7.80, 10.59, 13.14, 17.00, 100.29, 111.35, 121.52, 124.34, 128.18,
134.80, 135.52, 148.03, 150.94, 168.20 ppm.
5-Ethyl-1,2,3,6-tetramethylpyrrolo[2,3-f]indolizine-7,9-dione (4, C16H18N2O2)
Yield 47%; mp 211–213ꢄC; 1H NMR (CDCl3): ꢅ ¼ 1.20 (3H, t, J ¼ 7.7 Hz), 1.91 (3H, s), 2.08 (3H, s),
2.19 (3H, s), 2.50 (2H, q, J ¼ 7.7Hz), 4.00 (3H, s), 6.37 (1H, s) ppm; 13C NMR (CDCl3): ꢅ ¼ 8.15,
8.69, 9.90, 13.66, 17.92, 32.21, 99.42, 111.40, 121.78, 125.92, 128.29, 135.45, 137.37, 147.48, 153.08,
169.35 ppm.
Methyl 3,6-dimethyl-5-ethylpyrrolo[2,3-f]indolizine-7,9-dione-
2-carboxylate (5, C16H16N2O4)
1
Yield 65%; mp 298–300ꢄC (dec); H NMR ((CD3)2SO at 60ꢄC): ꢅ ¼ 1.16 (3H, t, J ¼ 7.6 Hz), 1.84
(3H, s), 2.39 (3H, s), 2.58 (2H, q, J ¼ 7.6 Hz), 3.82 (3H, s), 6.88 (1H, s), 12.73 (1H, br.s) ppm; 13C
NMR ((CD3)2SO at 60ꢄC): ꢅ ¼ 7.50, 9.41, 13.03, 17.02, 51.16, 99.63, 121.71, 125.06, 125.65, 126.09,
127.65, 135.35, 148.31, 151.21, 160.55, 167.85ppm.
Methyl 5-ethyl-1,3,6-trimethylpyrrolo[2,3-f]indolizine-7,9-dione-
2-carboxylate (6, C17H18N2O4)
Yield 35%; mp 219–220ꢄC; 1H NMR (CDCl3): ꢅ ¼ 1.22 (3H, t, J ¼ 7.7 Hz), 1.93 (3H, s), 2.37 (3H, s),
2.53 (2H, q, J ¼ 7.7 Hz), 3.91 (3H, s), 4.38 (3H, s), 6.44 (1H, s) ppm; 13C NMR (CDCl3): ꢅ ¼ 8.22,
10.85, 13.59, 17.98, 35.04, 51.66, 98.78, 122.45, 125.85, 126.64, 127.49, 128.24, 135.82, 147.74,
153.49, 161.81, 168.83 ppm.
Ethyl 8-ethyl-7-methylpyrrolo[3,2-f]indolizine-4,6-dione-3-carboxylate (7a, C16H16N2O4)
1
Yield 88% (crude product); mp 363–367ꢄC (dec); H NMR ((CD3)2SO at 90ꢄC): ꢅ ¼ 1.18 (3H, t,
J ¼ 7.6 Hz), 1.30 (3H, t, J ¼ 7.1Hz), 1.87 (3H, s), 2.57 (2H, q, J ¼ 7.6 Hz), 4.23 (2H, q, J ¼ 7.1 Hz), 6.69
(1H, s), 7.62 (1H, d, J ¼ 2.7 Hz), 12.00 (1H, br.s) ppm; 13C NMR ((CD3)2SO at 90ꢄC): ꢅ ¼ 7.35, 12.59,
13.66, 16.77, 59.08, 94.92, 113.67, 115.14, 126.33, 128.69, 137.54, 138.48, 146.21, 153.50, 162.22,
7
167.84ppm; HRMS (FAB, 3-NBA þ Li): calcd for C16H16N2O4 ꢂ Li 307.1270; found 307.1275.
Ethyl 8-ethyl-7-methyl-1-(3-methylbutyl)pyrrolo[3,2-f]indolizine-4,6-dione-
3-carboxylate (7b, C21H26N2O4)
To a mixture of 300 mg (1.0mmol) of 7a and 8 cm3 of anh. DMF under Ar was added Cs2CO3
(652 mg, 2.0mmol) followed by 1.3 cm3 (10.0 mmol) of iso-amyl iodide, and the mixture was stirred
at 85–90ꢄC for 16 h. After cooling, the product was partitioned between 100cm3 of CHCl3 and
100 cm3 of H2O. The organic layer was washed with 1% aq. HCl (100cm3) and H2O (4ꢅ 50cm3),
and then dried (anh. Na2SO4). After filtration and removal of solvent, the residue was purified by radial
chromatography and recrystallization from ethyl acetate–hexane to give 318 mg (86%) of 7b. Yield
1
86%; mp 158–159ꢄC; H NMR (CDCl3): ꢅ ¼ 0.96 (6H, d, J ¼ 6.6 Hz), 1.19 (3H, t, J ¼ 7.7 Hz), 1.38
(3H, t, J ¼ 7.2 Hz), 1.54–1.64 (1H, m), 1.66–1.70 (2H, m), 1.91 (3H, s), 2.51 (2H, q, J ¼ 7.7 Hz), 4.00
(2H, t, J ¼ 7.5 Hz), 4.35 (2H, q, J ¼ 7.2Hz), 6.26 (1H, s), 7.38 (1H, s) ppm; 13C NMR (CDCl3):